Value Bridge — ADVENTHEALTH WATERMAN
Current $-18M → Target $-11M (+$7.5M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-18.3M
Current EBITDA
$-10.8M
Target EBITDA
+$7.5M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$1.7M
Payer Mix Optimization
$4.1M
Cost to Collect Reduction
$1.4M
Clean Claim Improvement
$1.0M
Volume & Rate Growth
$6.8M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-18M to $-11M. The highest-impact lever is Volume & Rate Growth at $2.7M probability-weighted.
IC talking point: "We see $7M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $82M in equity value creation."